Anti-HLA class II antibodies in kidney retransplant patients

Tissue Antigens

Volumn 65, Issue 4, 2005, Pages 370-378

  Arnold, M L ^a   Pei, R ^b   Spriewald, B ^a   Wassmuth, Ralf ^c,d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Research Department   (United States)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alloreactivity; Anti HLA antibodies; Kidney transplantation

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; EPITOPE; HLA ANTIBODY; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-D ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; REOPERATION; TISSUE DONORS;

EID: 16344370430     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00382.x     Document Type: Article

References (29)

1. Sanfilippo F, Vaughn WK, Bollinger RR, Spees EK. Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 1982: 34: 360-6.
2. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969: 280: 735-9.
3. McKenna RM, Takemoto SK, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000: 69: 319-26.
4. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003: 3: 665-73.
5. Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002: 74: 1192-4.
6. Worthington JE, Martin S, Al Husseini DM, Dyer PA, Johnson RW. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003: 75: 1034-40.
7. Thompson JS, Thacker LR, Krishnan G. Human leukocyte antigens DR and AB and kidney retransplantation. Transplantation 2003: 75: 718-23.
8. Fuller A, Profaizer T, Roberts L, Fuller TC. Repeat donor HLA-DR mismatches in renal transplantation: is the increased failure rate caused by noncytotoxic HLA-DR alloantibodies? Transplantation 1999: 68: 589-91.
9. Iniotaki-Theodoraki A, Douramani P, Boletis J et al. Immune reactivity toward HLA class II determinants in renal transplantation. Transplant Proc 2001: 33: 461-4.
10. Taylor CJ, Chapman JR, Fuggle SV, Ting A, Morris PJ. A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft. Tissue Antigens 1987: 30: 104-12.
11. Iniotaki-Theodoraki AG, Boletis JN, Trigas GC, Kalogeropoulou HG, Kostakis AG, Stavropoulos-Giokas CG. Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period Transplantation 2003: 75: 1601-3.
12. Schonemann C, Groth J, Leverenz S, May G. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance. Transplantation 1998: 65: 1519-23.
13. Muller-Steinhardt M, Fricke L, Kirchner H, Hoyer J, Kluter H. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation. Clin Transplant 2000: 14: 85-9.
14. Harmer AW, Heads AJ, Vaughn RW. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients. Transplantation 1997: 63: 1828-32.
15. Christiaans MH, Nieman F, van Hooff JP, van den Berg-Loonen EM. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000: 69: 917-27.
16. Susal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002: 73: 1269-73.
17. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003: 75: 43-9.
18. van der Mast BJ, van Besouw NM, Witvliet MD et al. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression. Transplantation 2003: 75: 871-7.
19. Abe M, Kawai T, Futatsuyama K et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 1997: 63: 1616-9.
20. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003: 76: 395-400.
21. Cecka JM, Terasaki PI. Repeating HLA antigen mismatches in renal retransplants - a second class mistake? Transplantation 1994: 57: 515-9.
22. Opelz G. Repeated HLA mismatches increase the failure rate of second kidney transplants. Collaborative Transplant Study. Transplant Proc 1995: 27: 658-9.
23. Doxiadis II, de Lange P, D'Amaro J, de Meester J, Schreuder GM, Claas FH. Repeated HLA mismatches in cadaveric renal transplantation: is it safe to transplant? Transplant Proc 1997: 29: 1408-9.
24. Adeyi OA, Duquesnoy RJ. Serum analysis after kidney transplant nephrectomy reveals restricted antibody specificity patterns against donor HLA antigens. Hum Immunol 2003: 64: S109.
25. Mueller-Eckhardt G, Kiefel V, Tlusty A, Scholten J, Schmidt A, Mueller-Eckhardt C. Incidence and specificity of HLA-DP antibodies in pregnancy sera. Hum Immunol 1990: 29: 166-74.
26. Pfeiffer K, Vogeler U, Albrecht KH, Eigler FW, Buchholz B, Grosse-Wilde H. HLA-DP antibodies in patients awaiting renal transplantation. Transpl Int 1995: 8: 180-4.
27. Rosenberg WM, Bushell A, Higgins RM et al. Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplants. Hum Immunol 1992: 33: 5-9.
28. Mytilineos J, Deufel A, Opelz G. Clinical relevance of HLA-DPB locus matching for cadaver kidney retransplants. a report of the Collaborative Transplant Study. Transplantation 1997: 63: 1351-4.
29. Muczynski KA, Ekle DM, Coder DM, Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells, characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003: 14: 1336-48.